Home

Défilé Où Assassin gsk buy or sell Typique Chimie Cadre

GlaxoSmithKline reportedly looking to sell select antibiotic brands - PMLiVE
GlaxoSmithKline reportedly looking to sell select antibiotic brands - PMLiVE

GSK Raises Almost £1 Billion by Selling Another Haleon Stake - Bloomberg
GSK Raises Almost £1 Billion by Selling Another Haleon Stake - Bloomberg

GlaxoSmithKline Stock Forecast | Is GlaxoSmithKline a Good Stock to Buy?
GlaxoSmithKline Stock Forecast | Is GlaxoSmithKline a Good Stock to Buy?

Should You Sell GlaxoSmithKline plc (LON:GSK) At This PE Ratio?
Should You Sell GlaxoSmithKline plc (LON:GSK) At This PE Ratio?

FTSE 100: GSK Reaches Settlement in Zantac Lawsuit | Markets Insider
FTSE 100: GSK Reaches Settlement in Zantac Lawsuit | Markets Insider

GSK Raises $1 Billion Selling Shares in Haleon Spinoff - Bloomberg
GSK Raises $1 Billion Selling Shares in Haleon Spinoff - Bloomberg

GlaxoSmithKline to leave landmark global HQ after split-up as consumer  health business plots £120M new home | Fierce Pharma
GlaxoSmithKline to leave landmark global HQ after split-up as consumer health business plots £120M new home | Fierce Pharma

Sell AstraZeneca, says UBS, which upgrades European rivals including GSK -  MarketWatch
Sell AstraZeneca, says UBS, which upgrades European rivals including GSK - MarketWatch

GSK-HUL deal: HUL shares gain after Horlicks deal; should you buy or sell  stock? What brokerages say - Market News | The Financial Express
GSK-HUL deal: HUL shares gain after Horlicks deal; should you buy or sell stock? What brokerages say - Market News | The Financial Express

Pfizer Changes Its Mind, Will Sell Down Stake in GSK's Haleon Unit -  Investing.com India
Pfizer Changes Its Mind, Will Sell Down Stake in GSK's Haleon Unit - Investing.com India

GSK (GSK) Stock Price, News & Info | The Motley Fool
GSK (GSK) Stock Price, News & Info | The Motley Fool

The trading activity of the stock GSK between the 26500 − 28500'th... |  Download Scientific Diagram
The trading activity of the stock GSK between the 26500 − 28500'th... | Download Scientific Diagram

A GSK Dividend Cut Is Imminent - Should I Sell GlaxoSmithKline? - TEV
A GSK Dividend Cut Is Imminent - Should I Sell GlaxoSmithKline? - TEV

Buy, Sell or Hold: GlaxoSmithKline PLC (GSK-N) — Stock Predictions at  Stockchase
Buy, Sell or Hold: GlaxoSmithKline PLC (GSK-N) — Stock Predictions at Stockchase

GlaxoSmithKline and Pfizer to Merge Consumer Health Units - The New York  Times
GlaxoSmithKline and Pfizer to Merge Consumer Health Units - The New York Times

GSK Lifts Annual Outlook as Q3 Vaccine Sales Soar - TipRanks.com
GSK Lifts Annual Outlook as Q3 Vaccine Sales Soar - TipRanks.com

GSK Shares Gain on Analyst Upgrade, Price Target Boost - TipRanks.com
GSK Shares Gain on Analyst Upgrade, Price Target Boost - TipRanks.com

With 83% ownership of the shares, GSK plc (LON:GSK) is heavily dominated by  institutional owners - Simply Wall St News
With 83% ownership of the shares, GSK plc (LON:GSK) is heavily dominated by institutional owners - Simply Wall St News

GSK: Glaxo SmithKline Share Price Target 2023, 2025, 2027, 2030 to 2050 -  Sharedhan
GSK: Glaxo SmithKline Share Price Target 2023, 2025, 2027, 2030 to 2050 - Sharedhan

Glenmark Pharma & GSK Pharma: Top Stock Recommendation From Aditya Arora |  ET Now - YouTube
Glenmark Pharma & GSK Pharma: Top Stock Recommendation From Aditya Arora | ET Now - YouTube

GSK Consumer Healthcare's Horlicks sale could prove to be a sticky  attraction for some | Mint
GSK Consumer Healthcare's Horlicks sale could prove to be a sticky attraction for some | Mint

With $1.2B stock sale, GSK offloads more of its stake in consumer health  spinoff Haleon | Fierce Pharma
With $1.2B stock sale, GSK offloads more of its stake in consumer health spinoff Haleon | Fierce Pharma

GlaxoSmithKline Reportedly Trying Again to Sell Antibiotics Line | The  Motley Fool
GlaxoSmithKline Reportedly Trying Again to Sell Antibiotics Line | The Motley Fool

Is GSK a Strong Buy Right Now? | The Motley Fool
Is GSK a Strong Buy Right Now? | The Motley Fool

GSK plans to sell stake in Unilever's India unit: Report
GSK plans to sell stake in Unilever's India unit: Report

GSK raises $1.24 bln from latest Haleon stake sale | Reuters
GSK raises $1.24 bln from latest Haleon stake sale | Reuters